You have 9 free searches left this month | for more free features.

idarubicin

Showing 26 - 50 of 160

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

APL Trial in Valencia (Atra, Idarubicin, methotrexate)

Recruiting
  • APL
  • Valencia, Spain
    Hospital La Fe
Mar 22, 2021

Acute Myeloid Leukemia Trial in Tokyo (Quizartinib, Cytarabine, Idarubicin)

Completed
  • Acute Myeloid Leukemia
  • Tokyo, Japan
    (unnamed)
Jul 26, 2021

Lymphoma, Non-Hodgkin Trial in Worldwide (Ibrutinib, Rituximab, Ifosfamide)

Terminated
  • Lymphoma, Non-Hodgkin
  • Los Angeles, California
  • +76 more
Nov 7, 2022

Acute Myeloid Leukemia, FLT3-mutated Acute Myeloid Leukemia Trial in Japan, Korea, Republic of, Taiwan (gilteritinib,

Active, not recruiting
  • Acute Myeloid Leukemia
  • FLT3-mutated Acute Myeloid Leukemia
  • Anjo, Aichi, Japan
  • +54 more
Jan 10, 2023

Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blasts 10 Percent or More of Bone Marrow

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2022

Leukemia, Monocytic, Acute, Pediatric AML Trial in China (Cladribine, G-CSF, Cytarabine)

Recruiting
  • Leukemia, Monocytic, Acute
  • Pediatric AML
  • Foshan, Guangdong, China
  • +8 more
Mar 28, 2022

Acute Myeloid Leukemia (AML) Trial in Austria, Germany (Cytarabine, Idarubicin, Etoposide)

Completed
  • Acute Myeloid Leukemia (AML)
  • Innsbruck, Austria
  • +43 more
Dec 29, 2020

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +16 more
  • choline magnesium trisalicylate
  • +3 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Aug 20, 2021

Leukemia Trial in Houston (Clofarabine, Idarubicin, Cytarabine)

Completed
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 17, 2020

Leukemia, Myeloid, Acute Trial in Spain (Idarubicin, Ara-C, G-CSF)

Recruiting
  • Leukemia, Myeloid, Acute
  • Idarubicin
  • +5 more
  • Badalona, Barcelona, Spain
  • +14 more
Jul 30, 2021

Acute Myeloid Leukemia Trial in Augusta, Baltimore (Idarubicin, Cytarabine, Indoximod Freebase)

Completed
  • Acute Myeloid Leukemia
  • Idarubicin
  • +4 more
  • Augusta, Georgia
  • +1 more
Jun 3, 2020

Liver Cancer Trial in France (idarubicin, Dc- Beads 300-500µm)

Completed
  • Liver Cancer
  • idarubicin
  • Dc- Beads 300-500µm
  • Amiens, France
  • +6 more
Mar 27, 2020

Acute Myeloid Leukemia Trial in Boston (Alisertib, Cytarabine, Idarubicin)

Completed
  • Acute Myeloid Leukemia
  • Boston, Massachusetts
  • +1 more
Apr 23, 2020

Acute Myeloid Leukemia Trial in United States (CX-01, Idarubicin, Cytarabine)

Completed
  • Acute Myeloid Leukemia
  • La Jolla, California
  • +22 more
Sep 30, 2021

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Durham (Idarubicin, Cytarabine, DLI)

Completed
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Idarubicin
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Dec 1, 2020

Acute Myeloid Leukemia Trial in Spain (Quizartinib, Fludarabine, Cytarabine)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Alicante, Spain
  • +19 more
Mar 11, 2022

Acute Myeloid Leukemia Trial in Houston (Crenolanib besylate, Idarubicin, Cytarabine)

Completed
  • Acute Myeloid Leukemia
  • Crenolanib besylate
  • +7 more
  • Houston, Texas
    MD Anderson Cancer Center
Jul 17, 2020

AML in Remission Trial in Fuzhou (Idarubicin, ID cytarabine)

Recruiting
  • AML in Remission
  • Idarubicin
  • ID cytarabine
  • Fuzhou, Fujian, China
    Fujian Medical University Union Hospital
Jan 1, 2020

Acute Myeloid Leukemia (AML) Trial in Austria, Germany (Dasatinib, Cytarabine, Daunorubicin)

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • Innsbruck, Austria
  • +53 more
Sep 19, 2022

Acute Myeloid Leukemia (AML) Trial in France (Idarubicin, Daunorubicin, HD Cytarabine)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Idarubicin
  • +9 more
  • Amiens, France
  • +54 more
Oct 16, 2020

Leukemia Trial in United States (cytarabine, idarubicin, pravastatin sodium)

Active, not recruiting
  • Leukemia
  • Birmingham, Alabama
  • +184 more
Feb 4, 2022

Leukemia Trial in Houston (LY2510924, Idarubicin, Cytarabine)

Completed
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 14, 2019

Acute Myeloid Leukemia Trial in Worldwide (Magrolimab, Venetoclax, Azacitidine)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Magrolimab
  • +6 more
  • Duarte, California
  • +25 more
Feb 4, 2022

Acute Myeloid Leukemia Trial in Spain (Selinexor, fludarabine, idarubicin)

Completed
  • Acute Myeloid Leukemia
  • Badalona, Spain
  • +3 more
May 19, 2020

GVHD, Leukemia Trial (biological, drug, procedure)

Withdrawn
  • Graft Versus Host Disease
  • Leukemia
  • therapeutic allogeneic lymphocytes
  • +7 more
  • (no location specified)
Jul 29, 2020